Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.rmcr.2020.101226 http://scihub22266oqcxt.onion/10.1016/j.rmcr.2020.101226 32953446!7492163!32953446     free     free     free       Respir+Med+Case+Rep 2020 ; 31 (ä): 101226 Nephropedia Template TP {{tp|p=32953446|t=2020. Cystic fibrosis and COVID-19: Care considerations |pdf=|usr=}}{{32953446}} gab.com Text Cystic fibrosis and COVID-19: Care considerations JO: Respir Med Case Rep http://www.kidney.de/pget.php?&tw=1&pmid=32953446 #FOAvip The coronavirus disease 2019 (COVID-19) pandemic has demanded large scale changes in patient care. People with cystic fibrosis have unique considerations, including underlying lung disease and routine aerosolizing therapies, but there is insufficient evidence to create comprehensive practice guidelines. We share a case of a patient with CF and COVID-19 as well as alterations to routine CF care at a large academic center. Key considerations include accessible COVID-19 screening, augmented infection control practices, and rapid integration of telemedicine. Twit Text FOAVip Cystic fibrosis and COVID-19: Care considerations ????Respir Med Case Rep http://www.kidney.de/pget.php?&tw=1&pmid=32953446 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32953446 #FOAvip English Wikipedia <ref>{{Cite pmid|32953446}}</ref> Cystic fibrosis and COVID-19: Care considerations #MMPMID32953446 Mirza AA; Rad EJ; Mohabir PK Respir Med Case Rep 2020[]; 31 (ä): 101226 PMID32953446show ga The coronavirus disease 2019 (COVID-19) pandemic has demanded large scale changes in patient care. People with cystic fibrosis have unique considerations, including underlying lung disease and routine aerosolizing therapies, but there is insufficient evidence to create comprehensive practice guidelines. We share a case of a patient with CF and COVID-19 as well as alterations to routine CF care at a large academic center. Key considerations include accessible COVID-19 screening, augmented infection control practices, and rapid integration of telemedicine. äCystic fibrosis and COVID-19: Care considerations (epmc).pdf DeepDyve Pubget Overpricing